Synthesis of potent oxindole CDK2 inhibitors.
暂无分享,去创建一个
[1] Doris Marko,et al. Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases , 1999, Nature Cell Biology.
[2] S. Elledge,et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.
[3] C. Sherr. The Pezcoller lecture: cancer cell cycles revisited. , 2000, Cancer research.
[4] P. Gmeiner,et al. A Practical Ex-Chiral-Pool Synthesis of β-Proline and Homo-β-Proline , 1998 .
[5] Young-Tae Chang,et al. Targeting hyperproliferative disorders with cyclin dependent kinase inhibitors , 2000 .
[6] D. Seebach,et al. Preparation of Optically Active Alcohols from 1,3‐Dioxan‐4‐ones. A Practical Version of the Asymmetric Synthesis with Nucleophilic Substitution at Acetal Centers , 1986 .
[7] G. Mcmahon,et al. A novel cdk2-selective inhibitor, SU9516, induces apoptosis in colon carcinoma cells. , 2001, Cancer research.
[8] J. Leonard,et al. Preparation of proline derived lithium amide bases and their use in enantioselective deprotonation of meso epoxides , 1987 .
[9] B. Pramanik,et al. Diphenylphosphoryl azide a novel reagent for the stereospecific synthesis of azides from alcohols , 1977 .
[10] K. Webster,et al. Novel drugs targeting the cell cycle , 2000 .
[11] J. Nevins,et al. The Rb/E2F pathway and cancer. , 2001, Human molecular genetics.
[12] J. Harper,et al. Cyclin-dependent kinases. , 2001, Chemical reviews.
[13] F. Denizot,et al. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. , 1986, Journal of immunological methods.